Astellas Chairman and Daiichi Sankyo President Elected New Presidents Of FPMA And JPMA
This article was originally published in PharmAsia News
Two pharmaceutical industry trade associations elected new president at elections held May 21. Federation of Pharmaceutical Manufacturers Association of Japan elected Astellas Chairman Toichi Takenaka as its new president, and Japan Pharmaceutical Manufacturers Association elected Daiichi Sankyo President Takeshi Shoda as its new president. Takenaka and Shoda played leading roles in M&A of Fujisawa and Yamanouchi to create Astellas, and Sankyo with Daiichi. Attention will be focused on how they tackle a series of challenges facing the industry, such as drug pricing and global competition. (Click here for more - Japanese language)
You may also be interested in...
The company has no development programs left in its R&D pipeline and will focus entirely on the commercialization of IBS drug Linzess while seeking late-stage assets from external sources.
The documents issued by the US agency on 29 September set slightly different accuracy standards, reflecting the increased fragility of hospital patients.
The US FDA commissioner published a blog post commending and highlighting the work device center staff have done during the pandemic to speed tests and devices to market to save lives.